These studies have greatly increased our understanding of the mechanism of action of antiarrhythmic drugs, but the approach has tended to restrict the focus of attention to the heart, to the exclusion of extracardiac mechanisms.
Results from a small but growing number of studies have suggested that neural 5,11,28 hyperactivity may be important in the genesis of several types of arrhythmias, and that some antiarrhythmic drugs may antagonize these arrhythmias by their effects 4,11,26 _ on the nervous system rather than their direct effects on the heart.
For example, we recently found that administration of toxic doses of digitalis induced cardiac sympathetic hyperactivity concurrent with the development of ventricular arrhythmias and that administration of diphenylhydantoin abolished the neural hyperactivity coincident with reversion to normal sinus rhythm. 7 These results suggested that the neural excitatory actions of digitalis may be responsible for provoking arrhythmias and that the neurodepressant action of diphenylhydantoin may be responsible for its antiarrhythmic effect.
The primary purpose of the present study was to test more directly the hypothesis that the nervous system is a major site of action of diphenylhydantoin in antagonizing cardiac arrhythmias. An additional purpose was to compare the widely used antiarrhythmic agent lidocaine with diphenylhydantoin to determine the validity of the predominant view that these two drugs have the same mechanism of action. 9 In approaching this problem we set out to develop a model in which arrhythmias could be induced by stimulation of the brain while the neural activity to the heart could be simultaneously monitored. Our aim was then to study the action of diphenylhydantoin and lidocaine on this model to evaluate the neural component in the antiarrhythmic action of each drug.
II. METHODS
General procedures. Thirty-eight adult cats, unselected as to sex and ranging from 2.0 to 3.4 kg in weight, were anesthetized with an intravenous infusion of alpha chloralose (70-80 mg/kg), administered at a rate of 10 mg/min. After induction of anesthesia, the animals were immobilized with succinylcholine chloride (5 mg I. V.) and intubated. The animals were artificially ventilated with a gas mixture of 98. 5 percent oxygen and 1. 5 percent carbon dioxide using a Harvard respirator pump (Model 606) set to deliver tidal volumes of 25-40 cm 3 at rates of 25-30 breaths per minute. Continuous ventilation in this manner has been shown to maintain arterial blood pH between 20 7.31 and 7.43.
Adequacy of anesthesia was determined by the lack of any autonomic response (increase of heart rate or blood pressure) to a painful stimulus in the absence of succinylcholine. When indicated, additional doses of chloralose (5 mg/kg I.V.) were administered to insure adequate depth of anesthesia. The femoral artery and saphenous vein were catheterized for recording blood pressure and administering drugs, respectively. Continuous recordings were made of the electrocardiogram (Lead II) and the arterial blood pressure, using a Beckman type R B Dynograph. Body temperature was maintained at 37 -38 C with an infrared lamp.
Procedures employed for hypothalamic stimulation. The head of the cat was positioned in a stereotaxic apparatus, and a dorsal medial incision was made in the scalp. A 3-mm hole was drilled through the cranium at die desired anterior-posterior and lateral stereotaxic coordinate, and a bipolar stainless steel electrode (David Kopf NE-200) was lowered to the desired vertical stereotaxic coordinate. Points within the posterior hypothalamus were stimulated to evoke cardiac arrhythmias. The stereotaxic coordinates were: anterior 7.5-9.0 mm, lateral 1.0-2.0 mm, and vertical The stimulating electrode was connected to a Grass stimulator (Model S-4) through a stimulus isolation unit (Model SIU 478 A). Stimuli used were monophasic pulses of 8-14 volts, 1-5 msec in duration, applied at a rate of 80-120 Hz. Tissue resistance was measured between the two electrode poles at the beginning of each experiment and at intervals during the experiment. Tissue resistance ranged from 17 to 24 kohms in various experiments but remained constant during a given experiment. In each experiment, an attempt was made to locate points within the posterior hypothalamus which, when stimulated, produced maximal cardioacceleration and arrhythmias.
No attempt was made to duplicate specific stimulation points from animal to animal, rather, points were sought from which the desired cardiovascular response could be obtained.
In preliminary experiments, the arrhythmias produced by electrical stimulation of the posterior hypothalamus were only observed in about 50 percent of the animals.
Changing the site of stimulation within the posterior hypothalamus or changing the stimulus parameters did not increase the occurrence of arrhythmias. A similar lack of consistency in obtaining this type of arrhythmia has been reported by others. 10 ' 13 When arrhythmias failed to occur in our study, an increase in sinus rate was observed and appeared to mask the increase in rate of subatrial pacemakers. Because of this observation and the fact that sympathetic innervation of the sinus node is primarily 21 from the right sympathetic trunk, other preliminary experiments were performed in animals in which die sympathetic nerves on each side of the right stellate ganglion were sectioned. With the sympathetic influence to the sinus node removed, stimulation of the posterior hypothalamus consistently resulted in arrhythmias during stimulation. In addition, arrhythmias could be evoked numerous times in a given animal.
Therefore, the right preganglionic and postganglionic nerves to the heart were routinely sectioned in all subsequent experiments described in the present study.
Procedures employed for sympathetic nerve recordings. The stereotaxic apparatus was rotated 90 to allow access to the right thorax, and a thoracotomy was performed with resection of the first three or four ribs and the clavicle. The preganglionic sympathetic nerves to the right stellate ganglion were carefully dissected free from surrounding tissue and sectioned at a point proximal to their entrance into the ganglion. The central cut end of the sympathetic trunk was placed on bipolar platinum recording electrodes. Sectioning the nerve trunk distal to the point of recording was done to assure that only efferent sympathetic nerve activity would be recorded. In addition, as mentioned above, sectioning the right sympathetic nerves allowed us to readily obtain arrhythmias with electrical stimulation of the hypothalamus.
Although all of the results described in the present study were obtained using neurograms from the right cardiac sympathetic nerves, our preliminary studies, as 1 3 well as studies of other investigators, ' have demonstrated that the neurograms from both the right and left cardiac sympathetic nerves are bilaterally synchronous before and during periods of hypothalamic stimulation.
Nerve activity was amplified using a Tektronix Type 2 A 61 amplifier and was stored on electromagnetic tape. This activity was later displayed on an oscilloscope and photographed. In addition, nerve activity was quantitated by feeding it from the tape into a Grass integrator (Model 7 P10B). Both the nerve activity and the integration of the activity with respect to time were displayed on a Grass polygraph (Model 7).
The integrator was reset to zero at 10-second intervals, and the discriminator set so that only the positive activity was measured. Calibration of the integration system with reference to a known input was not done, as we were only interested in relative changes in activity. The method we used to measure the analog output of the integrator is described further in the Results section.
Procedures employed for peripheral sympathetic nerve stimulation. Experiments were also performed in which arrhythmias were produced by electrical stimulation of the cardiac preganglionic sympathetic nerves. The basic preparation was similar to that described above except that cats were subjected to spinal section at C-l and to bilateral cervical vagotomy. For sympathetic nerve stimulation, the left thoracic cavity was opened by excising the ribs on that side from the mammillary to the midaxil- 
III. RESULTS
Characterization of the arrhythmia. Electrical stimulation of points in the posterior hypothalamus produced an increase in heart rate and blood pressure and an alteration in cardiac rhythm. During hypothalamic stimulation the electrocardiogram revealed a progressive narrowing of the P-R interval until the P wave disappeared and a nodal rhythm predominated. These changes can be seen in panel A of Figure 1 . Restoration of sinus rhythm occurred within 5 to 15 seconds after termination of stimulation, and the transition to sinus rhythm appeared to be the reverse of the sequence that marked its occurrence.
The changes observed with stimulation suggested that the arrhythmia was mediated by the sympathetic nervous system. In support of this was the fact that the arrhythmia was always preceded by an increase in sinus rate and was associated with an increase in blood pressure ( Figure 1) . Furthermore, the rate of the abnormal rhythm was always faster than the control sinus rate. Finally, there were other signs of sympathetic hyperactivity, i.e. , mydriasis and contraction of the nictitating membrane.
To determine whether the arrhythmia, was mediated by the sympathetic nervous system, three experiments were performed in which propranolol (1.0 mg/kg I.V.) was administered after obtaining several control arrhythmias. In all three animals propranolol pretreatment prevented the arrhythmia. To rule out any participation from the parasympathetic nervous system in the generation of the arrhythmia, four experiments were performed in which either bilateral cervical vagotomy or administration of propantheline (1 mg/kg I. V.) was done after obtaining several control arrhythmias. In none of the four experiments was the arrhythmia prevented. However, subsequent administration of propranolol (0. 5 mg/kg I. V.) prevented the arrhythmia from occurring in all four animals. A representative experiment appears in Figure 2 . Results summarizing the effects of electrical stimulation of the posterior hypothalamus on blood pressure, heart rate and nerve activity are presented in Table I , They indicate that significant increases in pressure, rate, and nerve discharge occurred during stimulation. The rhythm change developed within a few seconds after the stimulation was initiated and persisted for 10.2 + 3. 24 seconds after the stimulation was terminated. The arrhythmia could be repeatedly evoked as many as 10 times in a given animal and was always evoked at least three consecutive times before testing the effects of drugs.
Effects of diphenylhydantoin. Six experiments were performed in which diphenylhydantoin was tested against arrhythmias and sympathetic hyperactivity induced by stimulation of the posterior hypothalamus. Hypothalamic stimulation was performed after each 5 mg/kg of diphenylhydantoin were infused until the arrhythmia was prevented. In each of the six animals, administration of 10 to 15 mg/kg (average of 11. 7 + 1.7 mg/kg) prevented both the arrhythmia and the high amplitude sympathetic neural discharge during hypothalamic stimulation. A representative experiment illustrating this effect is presented as Figure 3 .
The changes in cardiovascular parameters and nerve activity which occurred in the six experiments with stimulation of the posterior hypothalamus before and after diphenylhydantoin are summarized in Table II obtained during the prestimulation period (i.e., horizontal comparisons). Second, comparisons were made between data obtained before and after drug administration (i.e., vertical comparisons) and designated as the mean difference between the two experimental conditions. Prior to drug administration, hypothalamic stimulation resulted in significant increases in mean blood pressure, heart rate and nerve activity.
After diphenylhydantoin administration, hypothalamic stimulation produced a significant increase in nerve activity but no significant change in mean blood pressure or heart rate. With the second type of comparison, it can be seen that diphenylhydantoin administration resulted in a significant decrease in nerve activity during the initial (prestimulation) period and significant antagonism of the blood pressure rise and neural hyperactivity resulting from hypothalamic stimulation. In none of the six experiments was the arrhythmia prevented by diphenylhydantoin without attenuation of sympathetic nerve discharge.
Arrhythmias similar to those evoked by hypothalamic stimulation were evoked in cats with spinal cords transected by stimulation of the left preganglionic sympathetic trunk. In these experiments, sites of drug action within the central nervous system were excluded, making it possible to assess the contribution of peripheral action of the drug in antagonizing neurally induced arrhythmias.
Peripheral sympathetic stimulation, like hypothalamic stimulation, caused a progressive shortening of the P-R interval until a nodal rhythm predominated.
Cessation of stimulation resulted in emergence of the P wave with progressive widening of the P-R interval and a return to sinus rhythm. Four experiments were performed in which diphenylhydantoin was tested against arrhythmias induced by peripheral sympathetic nerve stimulation, and a representative one appears in Figure 4 . Stimulation was carried out after each 5 mg/kg of diphenylhydantoin were'infused.
In none of the four experiments was the arrhythmia prevented by diphenylhydantoin even though doses of from 20 to 40 mg/kg (average 26. 6 + 6.7 mg/kg) were administered. Indeed, diphenylhydantoin seemed to aggravate the arrhythmia. During the control period, the duration of the arrhythmia averaged 4 seconds; after diphenylhydantoin, the duration of the arrhythmia averaged 42 seconds (p < 0.05). Prolongation of the duration of arrhythmia can be noted in Figure 4 . The changes in cardiovascular parameters and integrated nerve activity which occurred in the four experiments with stimulation of the posterior hypothalamus before and after lidocaine are summarized in Table III . Significant increases in mean blood pressure, heart rate, and nerve activity occurred with hypothalamic stimulation prior to lidocaine administration. No significant increases in mean blood pressure or heart rate occurred with hypothalamic stimulation after lidocaine administration. On the other hand, the increase in nerve activity which occurred during stimulation was not affected by pretreatment with lidocaine. In addition, as mentioned above, arrhythmias were observed in each animal with stimulation before lidocaine but never occurred with stimulation after lidocaine. Finally, pretreatment with lidocaine produced significant reductions in the base mean blood pressure but had no significant effect on heart rate or the spontaneous discharge occurring in sympathetic nerves. As with lidocaine, methyllidocaine was tested for its ability to influence arrhythmias induced by peripheral sympathetic nerve stimulation (three experiments) and heart rate increases induced by intravenously administered norepinephrine (three experiments). Like lidocaine, methyllidocaine prevented the arrhythmia induced by peripheral sympathetic nerve stimulation in each of three experiments but did not modify the heart rate increase induced by intravenous norepinephrine.
IV. DISCUSSION
The purpose of our study was to determine whether or not a neurodepressant action is the mechanism whereby diphenylhydantoin and lidocaine exert their antiarrhythmic effect. To do this we developed a model for studying the effect of these drugs on neurogenic cardiac arrhythmias. The arrhythmia was produced by hypothalamic stimulation and was characterized by a progressive narrowing of the P-R interval until the P wave disappeared and a nodal rhythm predominated. This type of rhythm is 14 23 19 termed isorhythmic dissociation. ' Pick has listed the causes of dissociation as: (1) slowing of the primary pacemaker, (2) acceleration of subsidiary pacemakers, (3) A-V block, or (4) a combination of the above factors. In our experiments the isorhythmic dissociation appeared to be the result of an acceleration of A-V nodal pacemakers because no slowing in sinus rate occurred, and no evidence of A-V block was seen. This conclusion is further supported by the fact that the nodal rhythm was always faster than the sinus rate.
The arrhythmia'was further characterized by using procedures to determine which division of the autonomic nervous system mediated the response. Procedures employed were pretreatment with propantheline and propranolol as well as bilateral 3e was cervical vagotomy. Results clearly demonstrated that the rhythm disturbance mediated by sympathetic nerves. Arrhythmias similar to those produced with brain stimulation in the present study have been reported by Korteweg and colleagues. 10 They also observed rhythm changes during stimulation of the posterior hypothalamus of cats characterized by successive shortening of the P-R interval leading to a dominant nodal pacemaker. The authors stated that the arrhythmia could only occasionally be evoked by hypothalamic stimulation. In addition, these investigators found that bilateral vagotomy did not prevent the occurrence of this arrhythmia, suggesting sympathetic mediation.
Since the arrhythmias in the present study were shown to be mediated by the sympathetic nervous system, recordings from the preganglionic sympathetic trunk were used to determine whether a drug was exerting a central neurodepressant action in preventing the neurogenic arrhythmia. Evidence of a central neurodepressant site of action of an antiarrhythmic drug was attenuation of neural hyperactivity at the same time and at the same dose as prevention of the arrhythmia. Evidence of a peripheral neural or cardiac action of a drug was prevention of the arrhythmias induced by peripheral sympathetic stimulation in the absence of a functional central nervous system. Using these criteria, our results indicate that the antiarrhythmic action of diphenylhydantoin against neurogenic arrhythmias is due to a central nervous system depressive effect and not due to either a peripheral neural depressive effect or a direct cardiac effect of the drug. This conclusion is based on the finding that diphenylhydantoin administration prevented arrhythmias induced by electrical stimulation of the posterior hypothalamus. Doses of drug which were effective in preventing the arrhythi imias were also effective in preventing the autonomic neural hyperactivity responsible for the arrhythmias. In fact, the two effects of the drug were inseparable. Doses of the drug which were inadequate for preventing arrhythmias were inadequate for producing significant depression of sympathetic nerve activity. Furthermore, in no case was the arrhythmia prevented without a significant depression of sympathetic nerve activity.
The conclusion is also based on the finding that arrhythmias produced by electrical stimulation of peripheral sympathetic nerves were not prevented by diphenylhydantoin even in high doses. This is important evidence because it suggests that a peripheral nerve site as well as a direct cardiac site was not the responsible site of drug interaction in preventing the arrhythmia. In addition to the above evidence indicating a central nervous system site of action for diphenylhydantoin, we also observed that administration of this agent prevented the occurrence of other changes in cardiovascular function that reflect excessive neural activity. An example of this was the finding that the drug antagonized the increases in heart rate and blood pressure that were associated with posterior hypothalamic stimulation. Our results also do not rule out a myocardial site of action of lidocaine. We did find that lidocaine had no effect on the increases in sinus node automaticity induced by injected norepinephrine. We assumed that this test would reflect changes, if any, in the response of subatrial pacemakers to norepinephrine. Whether or not one can use responses of the normal pacemaker to sympathetic stimuli and extrapolate the findings to make predictions of the effects of drugs on responses of abnormal pacemakers to sympathetic stimuli has not been established. In summary, while the present studies have not excluded the heart as the site of antiarrhythmic action of lidocaine, our results suggest that peripheral neurodepression may explain its antiarrhythmic effects against arrhythmias caused by neural hyperexcitability.
The data from the present study provide a basis for considering the combined use of diphenylhydantoin and lidocaine for the therapy of arrhythmias. Until now, it has been assumed that these two drugs act at the same site and produce the same electrophysiological effects. Our study indicates that this assumption may not be true because the drugs exert their effects at different sites. Thus more effective therapy for arrhythmias with less dose of each drug may be achieved by the combined use of the two drugs.
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. The importance of the central nervous system in the antiarrhythmic actions of diphenylhydantoin and lidocaine was studied using arrhythmias induced by electrical stimulation of the posterior hypothalamus in cats. Hypothalamic stimulation resulted in cardiac arrhythmias mediated by the sympathetic nervous system. The arrhythmias occurred during stimulation, and recordings from cardiac sympathetic nerves revealed a continuous pattern of hyperactivity during the time of the arrhythmia. Administration of diphenylhydantoin (10-15 mg/kg I.V.) prevented both the arrhythmias and the hyperactivity in sympathetic nerves. Diphenylhydantoin had no effect on similar arrhythmias evoked by electrical stimulation of peripheral sympathetic nerves. Administration of lidocaine (2-6 mg/kg I.V.) prevented the arrhythmias produced by hypothalamic stimulation without attenuating sympathetic hyperactivity, and also prevented similar arrhythmias produced by stimulation of peripheral sympathetic nerves. Results identical to those obtained with lidocaine were observed with methyllidocaine, a quaternary derivative of lidocaine that does not easily penetrate the blood-brain barrier.
These results suggest that the antiarrhythmic action of diphenylhydantoin against neurogenic arrhythmias is due to its central neurodepressant action. The results further suggest that, in contrast to diphenylhydantoin, lidocaine acts at peripheral neural or cardiac sites to antagonize neurogenic arrhythmias. 
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